PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: November 3, 2014
Period of Report: November 3, 2014
Accession Number: 0001213900-14-007688

View Document ↗ View on SEC.gov ↗